Free hemoglobin concentration in severe sepsis: methods of measurement and prediction of outcome

Critical Care

Volumn 16, Issue 4, 2012, Pages

  Adamzik, Michael ^a   Hamburger, Tim ^a   Petrat, Frank ^a   Peters, Jürgen ^a   de Groot, Herbert ^a   Hartmann, Matthias ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CRITICAL ILLNESS; DEATH; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANK SUM TEST; RISK; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT; SIMPLIFIED ACUTE PHYSIOLOGY SCORE II; SPECTROPHOTOMETRY; SURVIVAL; SURVIVAL PREDICTION; BLOOD; ERYTHROCYTE TRANSFUSION; HOSPITAL MORTALITY; MIDDLE AGED; MORTALITY; ORGAN DYSFUNCTION SCORE; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; RISK FACTOR; SURVIVAL RATE;

AGED; BIOMARKERS; CALCITONIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBINS; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; ORGAN DYSFUNCTION SCORES; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN PRECURSORS; RISK FACTORS; SEPSIS; SPECTROPHOTOMETRY; SURVIVAL RATE;

EID: 84864800812     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11425     Document Type: Article

References (38)

1. Christaki E, Opal SM. Is the mortality rate for septic shock really decreasing?. Curr Opin Crit Care 2008, 14:580-586. 10.1097/MCC.0b013e32830f1e25, 18787453.
2. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG. The pathogenesis of sepsis. Annu Rev Pathol 2011, 28:19-48.
3. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801. 10.1016/j.cell.2006.02.015, 16497588.
4. Zedler S, Faist E. The impact of endogenous triggers on trauma-associated inflammation. Curr Opin Crit Care 2006, 12:595-601. 10.1097/MCC.0b013e3280106806, 17077693.
5. Davis JH, Yull AB. The red blood cell: an essential component of the toxicity of strangulation intestinal obstruction. Proc Soc Exp Biol Med 1961, 108:252-253.
6. Bloom O, Wang H, Ivanova S, Vishnubhakat JM, Ombrellino M, Tracey KJ. Hypophysectomy, high tumor necrosis factor levels, and hemoglobinemia in lethal endotoxemic shock. Shock 1998, 10:395-400. 10.1097/00024382-199812000-00003, 9872677.
7. Su D, Roth RI, Levin J. Hemoglobin infusion augments the tumor necrosis response to bacterial endotoxin (lipopolysaccharide) in mice. Crit Care Med 1999, 28:771-778.
8. Larsen R, Gozzelino R, Jeney V, Tokaji L, Bozza FA, Japiassú AM, Bonaparte D, Cavalcante MM, Chora A, Ferreira A, Marguti I, Cardoso S, Sepúlveda N, Smith A, Soares MP. A central role for free heme in the pathogenesis of severe sepsis. Sci Transl Med 2010, 2:51ra71. 10.1126/scitranslmed.3001118, 20881280.
9. Sheu CC, Zhai R, Wang Z, Gong MN, Tejera P, Chen F, Su L, Thompson BT, Christiani DC. Hemeoxygenase-1 microsatellite polymorphism and haplotypes are associated with the development of acute respiratory distress syndrome. Intensive Care Med 2009, 35:1343-1351. 10.1007/s00134-009-1504-6, 2758618, 19526221.
10. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256. 10.1097/01.CCM.0000050454.01978.3B, 12682500.
11. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963. 10.1001/jama.1993.03510240069035, 8254858.
12. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001, 286:1754-1758. 10.1001/jama.286.14.1754, 11594901.
13. Harboe M. A method for determination of hemoglobin in plasma by near-ultraviolet spectrophotometry. Scand J Clin Lab Invest 1959, 11:66-70. 10.3109/00365515909060410, 13646603.
14. Noe DA, Weedn V, Bell WR. Direct spectrophotometry of serum hemoglobin: an Allen correction compared with a three-wavelength polychromatic analysis. Clin Chem 1984, 30:627-630.
15. Fairbanks VF, Ziesmer SC, O'Brien PC. Methods for measuring plasma hemoglobin in micromolar concentration compared. Clin Chem 1992, 38:132-140.
16. Schaer DJ, Alayash AI. Clearance and control mechanisms of hemoglobin from cradle to grave. Antioxid Redox Signal 2010, 12:181-184. 10.1089/ars.2009.2923, 19788393.
17. Huffman DL, Bischof LJ, Griffitts JS, Aroian RV. Pore worms: using Caenorhabditis elegans to study how bacterial toxins interact with their target host. Int J Med Microbiol 2004, 293:599-607. 10.1078/1438-4221-00303, 15149037.
18. Aroian R, van der Goot FG. Pore-forming toxins and cellular nonimmune defenses (CNIDs). Curr Opin Microbiol 2007, 10:57-61. 10.1016/j.mib.2006.12.008, 17234446.
19. Gonzalez MR, Bischofberger M, Pernot L, van der Goot FG, Freche B. Bacterial pore-forming toxins: the (w)hole story?. Cell Mol Life Sci 2008, 65:493-507. 10.1007/s00018-007-7434-y, 17989920.
20. Bull BS, Kuhn IN. The production of schistocytes by fibrin strands (a scanning electron microscope study). Blood 1970, 35:104-111.
21. Heyes H, Köhle W, Slijepcevic B. The appearance of schistocytes in the peripheral blood in correlation to the degree of disseminated intravascular coagulation. An experimental study in rats. Haemostasis 1976, 5:66-73.
22. Ehrnthaller C, Ignatius A, Gebhard F, Huber-Lang M. New insights of an old defense system: structure, function, and clinical relevance of the complement system. Mol Med 2011, 17:317-329. 3060978, 21046060.
23. Pöschl JM, Leray C, Ruef P, Cazenave JP, Linderkamp O. Endotoxin binding to erythrocyte membrane and erythrocyte deformability in human sepsis and in vitro. Crit Care Med 2003, 31:924-928. 10.1097/01.CCM.0000055366.24147.80, 12627006.
24. Lang F, Gulbins E, Lang PA, Zappulla D, Föller M. Ceramide in suicidal death of erythrocytes. Cell Physiol Biochem 2010, 26:21-28. 10.1159/000315102, 20502001.
25. Hod EA, Zhang N, Sokol SA, Wojczyk BS, Francis RO, Ansaldi D, Francis KP, Della-Latta P, Whittier S, Sheth S, Hendrickson JE, Zimring JC, Brittenham GM, Spitalnik SL. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood 2010, 115:4284-4292. 10.1182/blood-2009-10-245001, 2879099, 20299509.
26. Bornside GH, Bouis PJ, Cohn I. Hemoglobin and Escherichia coli, a lethal intraperitoneal combination. J Bacteriol 1968, 95:1567-1571. 252177, 4870275.
27. Kaca W, Roth RI, Levin J. Hemoglobin, a newly recognized lipopolysaccharide (LPS)-binding protein that enhances LPS biological activity. J Biol Chem 1994, 269:25078-25084.
28. Roth RI, Kaca W, Levin J. Hemoglobin: a newly recognized binding protein for bacterial endotoxins (LPS). Prog Clin Biol Res 1994, 388:161-172.
29. Lin T, Kwak YH, Sammy F, He P, Thundivalappil S, Sun G, Chao W, Warren HS. Synergistic inflammation is induced by blood degradation products with microbial Toll-like receptor agonists and is blocked by hemopexin. J Infect Dis 2010, 202:624-632. 10.1086/654929, 2932749, 20617898.
30. Weinberg JA, Barnum SR, Patel RP. Red blood cell age and potentiation of transfusion-related pathology in trauma patients. Transfusion 2011, 51:867-873. 10.1111/j.1537-2995.2011.03098.x, 3086206, 21496048.
31. Belcher JD, Beckman JD, Balla G, Balla J, Vercellotti G. Heme degradation and vascular injury. Antioxid Redox Signal 2010, 12:233-248. 10.1089/ars.2009.2822, 2821146, 19697995.
32. Pishchany G, McCoy AL, Torres VJ, Krause JC, Crowe JE, Fabry ME, Skaar EP. Specificity for human hemoglobin enhances Staphylococcus aureus infection. Cell Host Microbe 2010, 8:544-550. 10.1016/j.chom.2010.11.002, 3032424, 21147468.
33. Tullius MV, Harmston CA, Owens CP, Chim N, Morse RP, McMath LM, Iniguez A, Kimmey JM, Sawaya MR, Whitelegge JP, Horwitz MA, Goulding CW. Discovery and characterization of a unique mycobacterial heme acquisition system. Proc Natl Acad Sci USA 2011, 108:5051-5056. 10.1073/pnas.1009516108, 3064333, 21383189.
34. Nieuwland R, Berckmans RJ, McGregor S, Böing AN, Romijn FP, Westendorp RG, Hack CE, Sturk A. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000, 95:930-935.
35. Figueiredo RT, Fernandez PL, Mourao-Sa DS, Porto BN, Dutra FF, Alves LS, Oliveira MF, Oliveira PL, Graça-Souza AV, Bozza MT. Characterization of heme as activator of Toll-like receptor 4. J Biol Chem 2007, 282:20221-20229. 10.1074/jbc.M610737200, 17502383.
36. Silva G, Jeney V, Chora A, Larsen R, Balla J, Soares MP. Oxidized hemoglobin is an endogenous proinflammatory agonist that targets vascular endothelial cells. J Biol Chem 2009, 284:29582-29595. 10.1074/jbc.M109.045344, 2785591, 19700768.
37. Fernandez PL, Dutra FF, Alves L, Figueiredo RT, Mourão-Sa D, Fortes GB, Bergstrand S, Lönn D, Cevallos RR, Pereira RM, Lopes UG, Travassos LH, Paiva CN, Bozza MT. Heme amplifies the innate immune response to microbial molecules through spleen tyrosine kinase (Syk)-dependent reactive oxygen species generation. J Biol Chem 2010, 285:32844-32851. 10.1074/jbc.M110.146076, 2963404, 20729208.
38. Gozzelino R, Jeney V, Soares MP. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 2010, 50:323-354. 10.1146/annurev.pharmtox.010909.105600, 20055707.